248 related articles for article (PubMed ID: 3496343)
1. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
Coffey RJ; Leof EB; Shipley GD; Moses HL
J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
[TBL] [Abstract][Full Text] [Related]
2. Interferon alpha/beta modulation of growth-factor-stimulated mitogenicity in AKR-2B fibroblasts.
Pietenpol JA; Howe PH; Cunningham MR; Leof EB
J Cell Physiol; 1989 Dec; 141(3):453-60. PubMed ID: 2687295
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
Mioh H; Chen JK
J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
Robinson RA; Branum EL; Volkenant ME; Moses HL
Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
Tucker RF; Volkenant ME; Branum EL; Moses HL
Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
[TBL] [Abstract][Full Text] [Related]
6. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.
Keski-Oja J; Lyons RM; Moses HL
Cancer Res; 1987 Dec; 47(24 Pt 1):6451-8. PubMed ID: 2890433
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor production by chemically transformed cells.
Moses HL; Branum EL; Proper JA; Robinson RA
Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
[TBL] [Abstract][Full Text] [Related]
8. Growth factor-independent proliferation of normal human neonatal keratinocytes: production of autocrine- and paracrine-acting mitogenic factors.
Cook PW; Pittelkow MR; Shipley GD
J Cell Physiol; 1991 Feb; 146(2):277-89. PubMed ID: 1999476
[TBL] [Abstract][Full Text] [Related]
9. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
Kanno H; Shinonaga M; Kuwabara T; Umeda M
No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.
Carr BI; Hayashi I; Branum EL; Moses HL
Cancer Res; 1986 May; 46(5):2330-4. PubMed ID: 3008986
[TBL] [Abstract][Full Text] [Related]
11. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of epidermal growth factor, transforming growth factor, and insulin on DNA and protein synthesis and morphology in serum-free cultures of AKR-2B cells.
Shipley GD; Childs CB; Volkenant ME; Moses HL
Cancer Res; 1984 Feb; 44(2):710-6. PubMed ID: 6362853
[TBL] [Abstract][Full Text] [Related]
13. Growth arrest of AKR-2B cells maintained in the presence of epidermal growth factor or 12-O-tetradecanoylphorbol-13 acetate: evidence for two separate G1 arrest points.
Moses HL; Proper JA; Volkenant ME; Swartzendruber DE
J Cell Physiol; 1980 Mar; 102(3):367-78. PubMed ID: 6967071
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity.
Cook PW; Ashton NM; Karkaria CE; Siess DC; Shipley GD
J Cell Physiol; 1995 May; 163(2):418-29. PubMed ID: 7706383
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the mitogenic response of an epidermal growth factor-dependent keratinocyte cell line by dexamethasone, insulin, and transforming growth factor-beta.
Zendegui JG; Inman WH; Carpenter G
J Cell Physiol; 1988 Aug; 136(2):257-65. PubMed ID: 2457593
[TBL] [Abstract][Full Text] [Related]
16. Effects of N,N-dimethylformamide and retinoic acid on transforming growth factor-beta induced mitogenesis in AKR-2B mouse embryo fibroblasts.
Levine AE; Crandall CA
Cancer Res; 1987 Aug; 47(16):4278-82. PubMed ID: 3496961
[TBL] [Abstract][Full Text] [Related]
17. Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-beta.
Rizzino A; Ruff E; Rizzino H
Cancer Res; 1986 Jun; 46(6):2816-20. PubMed ID: 3457628
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of serum and transforming growth factor beta (TGF-beta1)-induced DNA synthesis in confluent airway smooth muscle by heparin.
Okona-Mensah KB; Shittu E; Page C; Costello J; Kilfeather SA
Br J Pharmacol; 1998 Oct; 125(4):599-606. PubMed ID: 9831891
[TBL] [Abstract][Full Text] [Related]
19. Changes in receptor occupancy and growth factor responsiveness induced by treatment of a transformed mouse embryo cell line with N,N-dimethylformamide.
Levine AE; McRae LJ; Brattain MG
Cancer Res; 1985 Dec; 45(12 Pt 1):6401-5. PubMed ID: 2998599
[TBL] [Abstract][Full Text] [Related]
20. Production of transforming growth factors by human colon cancer lines.
Coffey RJ; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]